We are live on !
Find out more
Ardsley Advisory Partners Portfolio holdings
AUM
$940M
Turnover
62.86%
1-Year Est. Return
123.51%
This Fund
S&P 500
This Quarter Est. Return
+0.82%
1 Year Est. Return
+123.51%
3 Year Est. Return
+579.79%
5 Year Est. Return
+767.03%
10 Year Est. Return
+3,662.65%
AUM
$940M
AUM Growth
-$19.8M
(-2.1%)
Cap. Flow
-$72.4M
Cap. Flow % of AUM
Cap. Flow %
-7.7%
Top 10 Holdings %
Top 10 Hldgs %
32.28%
Holding
210
New
65
Increased
31
Reduced
38
Closed
67
Avg Time Held
Equity + Options
0.6
years
Top 10 Avg Time Held
Equity + Options
0.2
years
Top 20 Avg Time Held
Equity + Options
0.3
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$27.7M |
| 2 |
Synopsys
SNPS
|
+$18.7M |
| 3 |
Semtech
SMTC
|
+$16.8M |
| 4 |
Lumentum
LITE
|
+$13.5M |
| 5 |
BKV
BKV
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$45.3M |
| 2 |
United Therapeutics
UTHR
|
+$16.3M |
| 3 |
Sandisk
SNDK
|
+$15.6M |
| 4 |
Twilio
TWLO
|
+$14.2M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$12.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 46.56% |
| 2 | Miscellaneous | 17.84% |
| 3 | Healthcare | 9.69% |
| 4 | Industrials | 5.84% |
| 5 | Financials | 5.42% |
Similar funds
APFP
Ardsley Advisory Partners's Q3 2026 Portfolio in Review
As of Q3 2026, Ardsley Advisory Partners held 210 positions worth $940M, down 2.1% from $960M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ardsley Advisory Partners withdrew a net $72.4M in Q3 2026, closing 67 positions and reducing 38 holdings. Its most notable exit was United Therapeutics, an estimated $16.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 47% of assets, down from 48% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, Ardsley Advisory Partners opened a new position in Synopsys worth $20M.
- Ardsley Advisory Partners's largest Q3 2026 buy was Synopsys: 45,900 shares worth $20M.
- Ardsley Advisory Partners added most to Broadcom in Q3 2026, an estimated $27.7M increase.
- Ardsley Advisory Partners's biggest Q3 2026 reduction was Advanced Micro Devices, cutting an estimated $45.3M.
- Ardsley Advisory Partners fully exited United Therapeutics in Q3 2026, selling an estimated $16.3M.
- Ardsley Advisory Partners's ten largest holdings make up 32% of its $940M portfolio in Q3 2026.
- Ardsley Advisory Partners opened 65 new positions and closed 67 in Q3 2026.
- Ardsley Advisory Partners's portfolio value fell 2.1% quarter-over-quarter to $940M.
Based on Ardsley Advisory Partners's 13F filing for Q3 2026, filed 16 Nov 2026.